Clinical Trial Update: Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (CLERANCE) evaluating cabozantinib in hepatocellular carcinoma has completed. The document provides no trial results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED